Home / Drug shortages / Morphine Sulfate Injection

Morphine Sulfate Injection — FDA Drug Shortage

To Be Discontinued — Hospira, Inc., a Pfizer Company

The FDA lists a drug shortage record for Morphine Sulfate Injection (injection) from Hospira, Inc., a Pfizer Company with status To Be Discontinued. The shortage was first posted on 07/08/2025.

Shortage Details

Status
To Be Discontinued
Company
Hospira, Inc., a Pfizer Company
Package NDC
0409-1891-23
Dosage Form
Injection
Presentation
Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0409-1891-23)
Initial Posting
07/08/2025
Revised Date

FDA data resources